Cholesterol-lowering Decreased mTOR Complex 2 Signaling and Enhanced Antitumor ImmunityYanping Wang(Cedars-Sinai Medical Center), Hyung L. Kim(Cedars-Sinai Medical Center)medRxivFebruary 1, 202110.1101/2021.01.29.21250381Cited by 1SaveCiteExport RISWatch citationsRelated PapersA Comparison of Ku0063794, a Dual mTORC1 and mTORC2 Inhibitor, and Temsirolimus in Preclinical Renal Cell Carcinoma Models|PLoS ONE|2013|62Cholesterol-Lowering Intervention Decreases mTOR Complex 2 Signaling and Enhances Antitumor Immunity|Clinical Cancer Research|2021|30